Targeted Therapies in Low-Grade Serous Ovarian Cancers
Current Treatment Options in Oncology · 2024
DOI: 10.1007/s11864-024-01205-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, 2024. Verfasst von Anna Gonzalez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Molecular Targeted Therapy, Neoplasm Grading, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Opinion Statement Low grade serous carcinoma of the ovary has been delineated as a separate entity from its counterpart high grade serous carcinoma of the ovary. Molecular profiling has helped to further characterize this disease process and has led to new and exciting treatment options. Surgery has always been a cornerstone of management both in primary and recurrent disease settings. Chemotherapy has been a long-standing backbone of adjuvant treatment, but its efficacy continues to be questioned. Hormonal therapy for upfront and recurrent disease is an effective treatment option with a high response rate and minimal side effects. Newer therapies including MEK, CDK 4/6, and PI3KCA inhibitors have emerged as exciting options for recurrent disease. Ongoing clinical trials will hopefully lead to additional therapeutic opportunities based on novel biomarkers in this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, M-210 Starling Loving Hall, 320 W. 10th Avenue, C…
Zitieren
APA
Gonzalez, A., Nagel, C. I., & Haight, P. J. (2024). Targeted Therapies in Low-Grade Serous Ovarian Cancers. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-024-01205-4
Vancouver
Gonzalez A, Nagel CI, Haight PJ. Targeted Therapies in Low-Grade Serous Ovarian Cancers. Current Treatment Options in Oncology. 2024. doi:10.1007/s11864-024-01205-4
BibTeX
@article{Gonzalez2024,
author = {Gonzalez, Anna and Nagel, Christa I and Haight, Paulina J},
title = {Targeted Therapies in Low-Grade Serous Ovarian Cancers},
journal = {Current Treatment Options in Oncology},
year = {2024},
doi = {10.1007/s11864-024-01205-4}
}
EUVIMED